112 related articles for article (PubMed ID: 18094129)
1. Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Pfaller MA; Messer SA; Boyken L; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2008 Feb; 46(2):551-9. PubMed ID: 18094129
[TBL] [Abstract][Full Text] [Related]
2. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Pfaller MA; Diekema DJ; Messer SA; Boyken L; Hollis RJ
J Clin Microbiol; 2003 Apr; 41(4):1440-6. PubMed ID: 12682127
[TBL] [Abstract][Full Text] [Related]
3. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2005 Oct; 43(10):5208-13. PubMed ID: 16207985
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Pfaller MA; Messer SA; Hollis RJ; Jones RN; Diekema DJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1723-7. PubMed ID: 12019081
[TBL] [Abstract][Full Text] [Related]
5. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Rinaldi MG; Barnes R; Hu B; Veselov AV; Tiraboschi N; Nagy E; Gibbs DL
J Clin Microbiol; 2005 Dec; 43(12):5848-59. PubMed ID: 16333066
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
Pfaller MA; Diekema DJ; Messer SA; Boyken L; Hollis RJ; Jones RN;
J Clin Microbiol; 2003 Jan; 41(1):78-83. PubMed ID: 12517829
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2608-16. PubMed ID: 23740727
[TBL] [Abstract][Full Text] [Related]
8. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.
Pfaller MA; Diekema DJ; Sheehan DJ
Clin Microbiol Rev; 2006 Apr; 19(2):435-47. PubMed ID: 16614256
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Perea S; Gonzalez G; Fothergill AW; Sutton DA; Rinaldi MG
J Clin Microbiol; 2002 May; 40(5):1831-3. PubMed ID: 11980970
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Lortholary O; Dannaoui E; Raoux D; Hoinard D; Datry A; Paugam A; Poirot JL; Lacroix C; Dromer F;
Antimicrob Agents Chemother; 2007 Sep; 51(9):3378-80. PubMed ID: 17576839
[TBL] [Abstract][Full Text] [Related]
11. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.
Pfaller MA; Messer SA; Boyken L; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Jul; 42(7):3142-6. PubMed ID: 15243073
[TBL] [Abstract][Full Text] [Related]
12. Novel automated antifungal susceptibility testing system for yeasts based on dual-detection algorithm of turbidimetry and colorimetry.
Shen T; Liu P; Chen D; Liu D; Fang J; Wang Q; Xu Y; Tan C; Wang C
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38440953
[No Abstract] [Full Text] [Related]
13. Evaluation by data mining techniques of fluconazole breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) and comparison with those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
Cuesta I; Bielza C; Cuenca-Estrella M; Larrañaga P; Rodríguez-Tudela JL
Antimicrob Agents Chemother; 2010 Apr; 54(4):1541-6. PubMed ID: 20124002
[TBL] [Abstract][Full Text] [Related]
14.
Mirshekar M; Emami MH; Mohammadi R
Gastroenterol Hepatol Bed Bench; 2021; 14(3):260-266. PubMed ID: 34221266
[TBL] [Abstract][Full Text] [Related]
15. Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.
Watt K; Manzoni P; Cohen-Wolkowiez M; Rizzollo S; Boano E; Jacqz-Aigrain E; Benjamin DK
Curr Drug Metab; 2013 Feb; 14(2):193-202. PubMed ID: 22935068
[TBL] [Abstract][Full Text] [Related]
16. Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review.
Yerbanga IW; Nakanabo Diallo S; Rouamba T; Resendiz-Sharpe A; Lagrou K; Denis O; Rodriguez-Villalobos H; Montesinos I; Bamba S
J Mycol Med; 2023 Nov; 33(4):101413. PubMed ID: 37603962
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.
Kamai Y; Kubota M; Fukuoka T; Kamai Y; Maeda N; Hosokawa T; Shibayama T; Uchida K; Yamaguchi H; Kuwahara S
Antimicrob Agents Chemother; 2003 Feb; 47(2):601-6. PubMed ID: 12543666
[TBL] [Abstract][Full Text] [Related]
18. Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing.
Cuesta I; Bielza C; Larrañaga P; Cuenca-Estrella M; Laguna F; Rodriguez-Pardo D; Almirante B; Pahissa A; Rodríguez-Tudela JL
Antimicrob Agents Chemother; 2009 Jul; 53(7):2949-54. PubMed ID: 19433568
[TBL] [Abstract][Full Text] [Related]
19. MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method.
Borman AM; Fraser M; Palmer MD; Szekely A; Houldsworth M; Patterson Z; Johnson EM
J Fungi (Basel); 2017 May; 3(2):. PubMed ID: 29371545
[TBL] [Abstract][Full Text] [Related]
20. Identification and broth-microdilution antifungal susceptibility testing of yeast directly from automated blood cultures.
Das S; Tawde Y; Singh S; Chakrabarti A; Ray P; Rudramurthy SM; Kaur H; Ghosh A
Future Microbiol; 2020 Nov; ():1453-1464. PubMed ID: 33179527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
